These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33764414)

  • 1. Antithrombotic therapy in diabetes: which, when, and for how long?
    Ajjan RA; Kietsiriroje N; Badimon L; Vilahur G; Gorog DA; Angiolillo DJ; Russell DA; Rocca B; Storey RF
    Eur Heart J; 2021 Jun; 42(23):2235-2259. PubMed ID: 33764414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Capodanno D; Angiolillo DJ
    Circulation; 2020 Dec; 142(22):2172-2188. PubMed ID: 33253005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention.
    Siasos G; Skotsimara G; Oikonomou E; Sagris M; Vasiliki-Chara M; Bletsa E; Stampouloglou P; Theofilis P; Charalampous G; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2780-2788. PubMed ID: 32303164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapies in diabetes.
    Sagar RC; Naseem KM; Ajjan RA
    Diabet Med; 2020 May; 37(5):726-734. PubMed ID: 32141628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease.
    Park Y; Franchi F; Rollini F; Angiolillo DJ
    Circ J; 2016; 80(4):791-801. PubMed ID: 26984587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease.
    Rocca B; Rubboli A; Zaccardi F
    Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):92-105. PubMed ID: 31766921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
    Kearney K; Tomlinson D; Smith K; Ajjan R
    Cardiovasc Diabetol; 2017 Mar; 16(1):34. PubMed ID: 28279217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and Antithrombotic Therapy in Type I Diabetes Mellitus: Update on Current Data.
    Maragkoudakis S; Katsi V; Melidonis A; Soulaidopoulos S; Kolovou GD; Papazafeiropoulou AK; Trikkalinou A; Toutouzas K; Tsioufis K
    Curr Diabetes Rev; 2022; 18(9):e030122199792. PubMed ID: 34979890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.
    Nicolas J; Razuk V; Giustino G; Mehran R
    Future Cardiol; 2021 May; 17(3):521-534. PubMed ID: 33728965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study.
    Guan S; Xu X; Li Y; Li J; Guan M; Wang X; Jing Q; Huo Y; Han Y
    J Am Heart Assoc; 2020 Nov; 9(22):e013476. PubMed ID: 33164633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs.
    Patti G; Cavallari I; Andreotti F; Calabrò P; Cirillo P; Denas G; Galli M; Golia E; Maddaloni E; Marcucci R; Parato VM; Pengo V; Prisco D; Ricottini E; Renda G; Santilli F; Simeone P; De Caterina R;
    Nat Rev Cardiol; 2019 Feb; 16(2):113-130. PubMed ID: 30250166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic Therapy in Lower Extremity Artery Disease.
    Vrsalovic M; Aboyans V
    Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease.
    Capodanno D; Bhatt DL; Eikelboom JW; Fox KAA; Geisler T; Michael Gibson C; Gonzalez-Juanatey JR; James S; Lopes RD; Mehran R; Montalescot G; Patel M; Steg PG; Storey RF; Vranckx P; Weitz JI; Welsh R; Zeymer U; Angiolillo DJ
    Nat Rev Cardiol; 2020 Apr; 17(4):242-257. PubMed ID: 31953535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.
    Lettino M; Leonardi S; De Maria E; Halvorsen S
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):61-70. PubMed ID: 28618904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.
    Ferreiro JL; Cequier ÁR; Angiolillo DJ
    Diab Vasc Dis Res; 2010 Oct; 7(4):274-88. PubMed ID: 20921091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Poredos P; Jezovnik MK
    Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.